Healthtech & Wellness VC Funds

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Argon Ventures, based in Cambridge, Massachusetts, is a pre-seed venture fund focusing on Intelligent Industry Solutions. Founded by Robert Mason and Andrew Feinberg in 2020, Argon Ventures targets early-stage investments in Big Data & Analytics, SaaS, and Software sectors. The firm leverages its deep operational expertise to support founders in building impactful global businesses. Notable investments include companies like EnFi, Cyvl.ai, and PeakMetrics, reflecting Argon's commitment to high-tech, data-driven solutions. Argon Ventures typically leads rounds with an average investment size of around $2M, showing a preference for hands-on engagement from the earliest stages. The firm has built a strong co-investor network, collaborating with prominent investors such as Techstars and Glasswing Ventures. Argon Ventures is characterized by its proactive support in areas like team building, product strategy, and market entry. The team, including seasoned professionals like Bob Mason, brings a combination of technical insight and business acumen, helping startups navigate their growth journeys effectively. With a robust portfolio and a strategic focus on innovative tech solutions, Argon Ventures positions itself as a key player in the venture capital landscape, fostering the next generation of transformative companies.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkitekt Ventures is a New York-based venture capital firm focused on advancing human health through early-stage investments. Their portfolio emphasizes innovative healthcare solutions, including digital health platforms, biotech, and frontier technologies like neurotech, AI, and bioengineering. Notable recent investments include Sollis Health, Nanite, and Mural Health, with check sizes ranging from $3M to $15M. Arkitekt primarily invests in the U.S. but has also backed companies in the UK, maintaining a sector focus in healthtech, medical devices, and life sciences. Their strategy centers on pre-seed to Series A stages, preferring startups with groundbreaking approaches to healthcare delivery and precision medicine. They rarely lead rounds but frequently co-invest with prominent partners like Bessemer Venture Partners and Torch Capital. Led by managing director Enke Bashllari and partner Pavan Choksi, Arkitekt Ventures values long-term partnerships and tends to back visionary founders who are leveraging cutting-edge science. Their team prefers a data-driven, relationship-building approach, and startups seeking funding should ideally present transformative technologies with strong early traction.

Arkley Brinc VC is a venture capital firm based in Warsaw, Poland, that focuses on early-stage investments in hardware-enabled startups, particularly in IoT, MedTech, and smart manufacturing sectors. The firm was established as a joint initiative between Arkley, a European pioneer in hardware investments, and Brinc, a global accelerator known for its deep connections in China’s manufacturing hubs. This partnership allows Arkley Brinc to offer startups not only capital but also a wealth of resources for product development, manufacturing, and global distribution. With a fund size of $15 million, Arkley Brinc invests up to $1 million per company, supporting them from the prototype stage through to IPO. The firm’s investments are concentrated in Poland and across Europe, leveraging its strategic networks to help startups scale effectively. Arkley Brinc has a strong track record, with over 50 projects supported and several successful exits and IPOs. The firm’s team consists of serial entrepreneurs and finance professionals with extensive experience in launching and scaling technology businesses. The Arkley Launchpad program is another key initiative, offering a highly individualized acceleration program designed to raise successful funding rounds and drive operational success. This program is tailored to the specific needs of each startup, providing access to a network of partners in prototyping, manufacturing, sales, and investment.

Armilar Venture Partners is a leading venture capital firm based in Lisbon, Portugal, with a strong international presence. Since its founding in 2000, Armilar has focused on early-stage technology-based companies, particularly in sectors where data, digitization, and connectivity are central. Notable investments include OutSystems, Feedzai, and Vawlt, showcasing their commitment to companies driving digital transformation. Armilar specializes in deep-tech investments, supporting startups that leverage cutting-edge technology to address significant societal challenges. They have a hands-on approach, providing not only capital but also strategic guidance to help their portfolio companies scale effectively. Their investment strategy includes focusing on companies with strong intellectual property and significant market potential, often leading funding rounds to ensure their startups have the resources needed for success. Geographically, while Armilar has a strong focus on Portugal, they are open to investing globally, demonstrating flexibility in finding and supporting the best opportunities regardless of location. Their investment strategy is characterized by patience and long-term support, often leading funding rounds and staying engaged through critical growth phases. The firm has a notable team, including Joaquim Rodrigues, the founder, and managing partners like Nuno Leite and Pedro Santos. These leaders bring extensive experience and a deep understanding of both technology and market dynamics, ensuring they can provide valuable support to their portfolio companies.

Arnold Venture Group is a Pacific Northwest-based venture capital firm that focuses on innovative companies across sectors like information technology, software, infrastructure, and business intelligence. Established in 2018, the firm invests in early to growth-stage companies, with check sizes ranging from $250K to $5M. Arnold Venture Group places a strong emphasis on companies with social impact, making strategic investments in the U.S. market. The firm has a diverse portfolio that includes sectors like media, healthcare, and food/agriculture. Notable investments include Videon Labs, AdaptX, and Picnic, demonstrating their wide-reaching impact across different industries. Arnold Venture Group typically co-invests alongside other well-known venture firms such as Voyager Capital and Vulcan, further enhancing its reach and network. Led by a small, experienced team, including partners Cole Younger and Robert Arnold, the firm supports its portfolio companies by leveraging deep industry knowledge and strategic connections. With its focus on scaling impactful companies, Arnold Venture Group continues to be a strong player in the venture capital ecosystem.

Array Ventures, founded in 2015 and based in San Francisco, focuses on early-stage investments in enterprise technology startups. The firm is led by Shruti Gandhi, who leverages her extensive background in software engineering and venture capital to support innovative companies. Array Ventures primarily invests in enterprise SaaS, data, AI, security, infrastructure, and cloud technologies. They typically invest between $250,000 to $2 million in pre-seed and seed rounds, aiming for 8-15% ownership in their portfolio companies. Notable investments by Array Ventures include Simility (acquired by PayPal), CasaOne, Blumira, MadStreet Den, Modal, and Uniform.dev. The firm has a strategic focus on founders with strong technical backgrounds who are leaving lucrative corporate jobs to tackle significant problems. They provide robust support to help these startups grow from initial stages to achieving significant ARR milestones. Array Ventures also has a global investment approach, backing companies that address worldwide markets, including notable investments in Indian and Israeli startups.

Artesian Investments, founded in 2004 by Jeremy Colless, Matthew Clunies-Ross, and John McCartney, is a global alternative investment management firm specializing in venture capital, public and private debt, and impact investment strategies. Based in Sydney, the firm has expanded its reach with offices in Melbourne, Adelaide, Shanghai, Jakarta, Singapore, London, and New York​​. Artesian's notable investments include Instaclustr, PouchNATION, and Regrow Ag. They are particularly active in the Asia-Pacific region, managing over $1.22 billion in assets and boasting more than 600 startup investments​ (Artesian)​. Their investment strategy focuses on early-stage ventures across various sectors, including technology, agrifood, medtech, and AI. Artesian also offers a unique "Venture Capital as a Service" (VCaaS) platform, providing customized investment solutions to corporations, government, and family offices​. The firm places a strong emphasis on ESG (Environmental, Social, and Governance) criteria and impact investing, aiming to deliver sustainable returns while addressing critical global challenges. Artesian is a certified B Corp, underscoring their commitment to positive social and environmental impact. Key team members include Jeremy Colless (CEO), Matthew Clunies-Ross (CIO), and Luke Fay (Partner, Australian Venture Capital). Their diversified team spans multiple continents, bringing extensive expertise and a global perspective to their investment activities

Arthur Ventures, established in 2008 and headquartered in Minneapolis, Minnesota, focuses on investing in early-stage B2B software companies across the U.S. and Canada. They emphasize backing startups located outside Silicon Valley, promoting innovation and growth in diverse regions. Arthur Ventures' portfolio includes a variety of successful companies. Notable investments feature DataCamp, an online data science training platform; Protenus, which offers patient data protection; and ThreatLocker, a zero-trust endpoint security solution. Other significant portfolio companies include Jane.app, a practice management software for health and wellness clinics, and CertifID, a network management software company. The firm has made over 102 investments and has seen 18 exits, with companies like Ionic and TINYpulse achieving successful outcomes. Arthur Ventures focuses on sectors such as SaaS, cybersecurity, fintech, and healthcare IT, providing capital and strategic support to help early-stage companies grow and succeed.

Artiman Ventures, founded in 2001, is a venture capital firm based in Silicon Valley with an additional office in Bangalore. The firm specializes in early-stage investments and adopts a "white space" investment strategy, focusing on sectors with little to no existing competition, thereby seeking to create or disrupt multi-billion dollar markets. Artiman is sector-agnostic and invests across a diverse range of industries including technology, medtech, and communications. Notable investments in Artiman's portfolio include companies like Virsec, which focuses on application security, and Visby Medical, which is revolutionizing disease diagnostics. Other significant investments include ApplyBoard, an AI-enabled marketplace for international students, and CellMax Life, a precision cancer blood-testing company. Geographically, Artiman primarily invests in companies based in the U.S. and India, leveraging its cross-border presence to help startups scale globally. Their investment strategy involves being the first institutional capital, often at the concept phase, and working closely with entrepreneurs to drive strategy, market definition, and execution​. The leadership team at Artiman includes experienced partners like Yatin Mundkur, Amit Shah, and Ajit Singh, who bring deep expertise in technology and life sciences investments. Founder Eric Benhamou, known for his tenure as CEO of 3Com and Palm, leads the team with a strong background in growing and managing tech companies.

Artis Ventures (AV) is a pioneering venture capital fund that specializes in the convergence of technology and biology, a field they have coined "TechBio." This innovative approach leverages advancements in AI, machine learning, and data science to transform healthcare and life sciences, aiming for scalable global impact. Notable investments include Rad AI, which uses artificial intelligence to enhance radiology, and Precision Neuroscience, a leader in neuroplasticity-promoting therapeutics. AV primarily focuses on data-driven life sciences companies that address critical healthcare challenges and are capable of achieving broad, scalable impact. Their industry scope spans oncology, cardiopulmonary, neurology, and beyond, often targeting companies with strong engineering and data science foundations. Geographically, AV invests globally, supporting founders from over 30 countries to foster innovations that can be scaled worldwide. The fund's strategy is centered around investing in early-stage startups with robust technical foundations and significant potential for positive health outcomes. They prefer to lead investment rounds and actively engage with their portfolio companies, offering not just capital but also strategic support and access to a vast network of industry experts. AV's investment team includes prominent figures like Laura Bordewieck Rippy and Luke Antal, who bring extensive experience and a strong track record in venture capital and entrepreneurial support. They are based in San Francisco, a hub for tech and biotech innovation. For startups looking to engage with AV, it's crucial to demonstrate a clear vision for scalable health solutions backed by solid technical expertise. AV values a data-driven approach and is keen on companies that can show potential for significant, measurable impact on global health outcomes.

Asahi Kasei Ventures is the corporate venture capital arm of Asahi Kasei, a diversified Japanese conglomerate with major operations in materials, homes, and healthcare. The venture fund focuses on early-stage investments globally, with a particular emphasis on startups that align with Asahi Kasei's strategic interests, such as advanced materials, healthcare innovations, and sustainability technologies. The fund is particularly active in sectors like hydrogen energy, carbon management, and bio-based chemicals, supporting startups that contribute to environmental sustainability. Asahi Kasei Ventures operates from key locations including Tokyo, Düsseldorf, and Shanghai, ensuring a broad geographic reach to identify and support innovative technologies worldwide. Asahi Kasei Ventures not only provides financial support but also leverages the vast resources and expertise of the broader Asahi Kasei Group, which has over 287 subsidiaries and a significant global footprint. This enables startups in their portfolio to benefit from deep industry knowledge, extensive networks, and strategic partnerships to accelerate their growth and impact.

Ascension Ventures is a strategic healthcare-focused venture capital firm based in St. Louis, Missouri. Launched in 2001 by Ascension, it manages over $1 billion in assets across five funds. The firm strategically invests in early to late-stage companies within healthcare services, health technology, and medical devices. Its unique approach connects more than 450 healthcare providers, creating an ecosystem that enables startups to directly engage with health system executives, driving solutions that address complex healthcare challenges. Ascension Ventures’ portfolio includes companies like Olive (an AI platform for healthcare administration), EBR Systems, and GetWellNetwork, reflecting its emphasis on technology that enhances clinical outcomes, patient experience, and operational efficiency. The firm typically invests between Series A and B rounds, with capital sizes ranging from $10 to $20 million per company, often seeking board seats or observer rights to guide their portfolio firms. The firm is distinguished by its close ties to 13 major health systems, which represent a network of over 580,000 healthcare professionals. This strategic positioning allows Ascension Ventures not only to provide funding but also to facilitate partnerships and scale innovations that improve healthcare delivery across the United States.

Asha Impact, founded in 2014 by Vikram Gandhi and Pramod Bhasin, is an impact investment platform based in New Delhi. It focuses on sectors that address key social challenges in India, such as financial inclusion, education, healthcare, agriculture, and clean energy. By blending venture capital with philanthropy, Asha Impact supports early-stage companies that deliver scalable solutions to these pressing issues. The firm is known for backing startups like Adda247, an edtech platform, and Truemeds, a healthcare company providing affordable medicine. Asha Impact typically invests in early and growth-stage businesses, often alongside other prominent venture capital firms. The platform’s approach emphasizes creating sustainable impact while also generating strong financial returns, working closely with its portfolio companies to guide their growth. Asha Impact is committed to fostering a more equitable future by empowering businesses that contribute to social and economic progress across India and other emerging markets.

Asimov Ventures is an early-stage venture capital firm with offices in New York City and Palo Alto. The firm focuses on investing in cutting-edge technologies such as 3D printing, robotics, and advanced computing. Asimov Ventures seeks to partner with visionary entrepreneurs dedicated to transforming their industries through innovative solutions. Notable investments by Asimov Ventures include Particle3D, which specializes in 3D-printed bone implants, and Kadena, a blockchain technology company. The firm also invests in various other sectors, including healthcare, e-commerce, and augmented reality, reflecting their broad interest in transformative technologies​. Asimov Ventures typically participates in funding rounds with other notable investors, providing capital and strategic support to help startups scale and succeed. Their investment strategy emphasizes early-stage companies with strong intellectual property and commercial potential​.

Aspect Ventures, founded in 2014 by Jennifer Fonstad and Theresia Gouw, is a leading venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments, primarily in Series A rounds, across various sectors including cybersecurity, fintech, digital health, and enterprise software. Notable investments include Gusto, a cloud-based HR management platform; Chime, a digital bank; and Exabeam, a cybersecurity company. Aspect Ventures has had several successful exits such as Forescout Technologies, Imperva, and Trulia.

Astanor Ventures, founded in 2017 by Eric Archambeau and George Coelho, is a Brussels-based venture capital firm specializing in sustainable agrifood technologies. The firm focuses on investing in early-stage, mission-driven companies that address significant social or environmental issues within the agrifood value chain. This includes sectors like regenerative agriculture, bioeconomy, and climate-positive solutions. Astanor recently closed its second venture fund at €360 million, bringing its total assets under management to €800 million. This fund will support innovative solutions aimed at transforming the global food system to be more sustainable and resilient​. The firm boasts an extensive network of entrepreneurs, experts, scientists, and policymakers, which helps identify and nurture groundbreaking technologies. Notable investments include companies that advance autonomous electric agricultural machinery, high-functioning proteins, and genomic sequencing for sustainable food production.

Astarc Ventures, established in 2015, is the corporate venture arm of Astarc Group based in Mumbai, India. The fund focuses on early-stage investments in innovative technology companies across various sectors, including fintech, healthtech, logistics, AI/ML, and e-commerce. Notably, Astarc Ventures invests globally, with a presence in markets like India, Israel, the United States, and the United Kingdom. The firm typically supports entrepreneurs whose ventures align with Astarc Group's strategic interests and disruptive technologies. With over 60 investments, Astarc Ventures has backed companies such as Rooter, Purple Style Labs, Jai Kisan, and Dataloop. These investments span diverse industries from AI-driven solutions to consumer marketplaces and climate-tech. The firm is also known for its exits, including Liv.ai, which was acquired by Flipkart in 2018. Led by Executive Director Salil Musale and an experienced team, Astarc Ventures leverages deep operational expertise to help portfolio companies scale. The team takes an active role in guiding startups, offering both strategic advice and operational support, especially in emerging sectors.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

AstraZeneca is a leading global biopharmaceutical company with a strong focus on oncology, biopharmaceuticals, and rare diseases. They are committed to discovering, developing, and delivering innovative medicines that transform the lives of patients worldwide. AstraZeneca's oncology portfolio is particularly noteworthy, with a significant emphasis on creating groundbreaking cancer treatments. Their strategy includes leveraging various scientific platforms such as antibody-drug conjugates (ADCs), radioconjugates, and T cell engagers. Recent high-profile deals include collaborations with Daiichi Sankyo for ADCs and the acquisition of Neogene Therapeutics to enhance their T cell receptor therapy capabilities​​. In addition to oncology, AstraZeneca has a robust pipeline in biopharmaceuticals aimed at addressing chronic diseases and enhancing long-term health outcomes. They are also advancing treatments for rare diseases, expanding their reach globally to ensure broader access to their innovative therapies​​. AstraZeneca's business development approach is integral to their growth, focusing on strategic alliances and partnerships. This includes collaborations with companies like Tempus for AI-enabled precision medicine and various biotech firms to accelerate advancements in areas like epigenetics and undruggable targets​​. The company emphasizes a culture of innovation, diversity, and sustainability, aiming to make a significant impact on global health while maintaining environmental responsibility through initiatives like Ambition Zero Carbon​.

Asymmetric Financial is a venture capital firm that focuses on investing in early-stage companies within the fintech, software, and digital health sectors. Founded by Joe McCann in 2022, the firm operates with a unique approach to venture capital, combining deep expertise in technology and finance to support companies that are poised to disrupt traditional industries. Asymmetric Financial aims to identify and back innovative startups that leverage advanced technologies such as artificial intelligence, blockchain, and big data analytics to create new market opportunities. The firm’s investment strategy is centered on providing not only capital but also strategic guidance and operational support. Asymmetric Financial works closely with its portfolio companies to help them scale efficiently, offering assistance in areas such as financial planning, go-to-market strategies, and key performance indicator (KPI) development. This hands-on approach ensures that the startups in their portfolio are well-equipped to navigate the challenges of rapid growth and market competition. Asymmetric Financial is particularly interested in companies that have the potential to generate significant returns while also creating meaningful impact through their innovations. By focusing on sectors that are at the intersection of technology and finance, the firm aims to contribute to the modernization and transformation of the financial services industry.

Asymmetric Capital Partners (ACP) is a venture capital firm focused on backing B2B technology companies from Seed to Series C stages. Founded in 2020 by Rob Biederman, former co-CEO of Catalant Technologies, ACP manages an oversubscribed debut fund of $105 million. The firm targets disruptive businesses in areas like healthcare IT, fintech, marketplaces, and next-gen software, especially those transforming legacy industries and capitalizing on digital innovation. ACP is known for its hands-on approach, leveraging a team of founders and former operators who work closely with startups on strategic growth areas such as hiring, go-to-market strategies, and financial planning. They typically invest between $2M to $10M, with the flexibility to co-invest in larger deals alongside top firms like Andreessen Horowitz and Sequoia Capital. Some notable investments include Firstbase, a remote work platform backed by Andreessen Horowitz, and Clearco, a fintech company. The firm prides itself on being deeply involved with its portfolio companies, providing both operational support and access to a vast network of advisors and industry experts.

Asymmetry Ventures, based in San Francisco, is a prominent early-stage venture capital firm founded by Rob Ness. The firm focuses on investing in transformative startups that have the potential to create significant impact. They have a diverse portfolio of over 280 investments, including notable companies like BillionToOne, Foresight Mental Health, Mast Reforestation (formerly DroneSeed), and Orbit Fab. Asymmetry Ventures is known for their commitment to supporting defensible businesses, particularly in sectors such as artificial intelligence, biotechnology, and aerospace. They typically make initial investments in the range of $2 million and have been involved in notable funding rounds such as Orbit Fab's $10 million raise, which also saw participation from major aerospace players like Northrop Grumman and Lockheed Martin. The firm prides itself on identifying and backing visionary founders and innovative business models, with a strong emphasis on early-stage investments that leverage technology to create natural barriers to entry and generate recurring revenue streams. They also prioritize investments that address significant market needs with scalable solutions. For startups looking to partner with Asymmetry Ventures, demonstrating a strong leadership team and a clear path to market dominance are crucial. The firm's deep network and extensive industry experience provide valuable support and guidance to their portfolio companies, enhancing their potential for growth and success.

AT Inc, now known as Amazon Catalytic Capital, is Amazon’s venture capital initiative with an initial commitment of $150 million aimed at supporting underrepresented founders. The fund invests in venture capital funds, accelerators, incubators, and venture studios that prioritize startups led by Black, Latino, Indigenous, women, and LGBTQIA+ entrepreneurs. This initiative not only provides financial backing but also offers mentorship from Amazon executives and access to resources that can aid in business and technical strategy. Key investments include Collide Capital, Elevate Future Fund, Share Ventures, and Techstars Rising Stars Fund. These funds focus on diverse founders working in areas such as clean energy, fintech, health tech, and consumer goods. Amazon’s goal is to foster inclusion and innovation, ultimately driving economic growth and creating generational wealth for historically underserved communities.

At One Ventures is a venture capital firm founded in 2020 by Tom Chi, a founding member of Google X. The firm is dedicated to investing in early-stage startups that are developing disruptive deep tech solutions aimed at making humanity a net positive to nature. With a strong focus on climate tech, At One Ventures has established itself as a significant player in the industry. The firm recently closed its second fund at $375 million, indicating strong investor confidence and a robust commitment to supporting climate-positive innovations. This fund follows their initial $150 million fund and aims to support startups that can dramatically reduce environmental footprints while upending established industrial economics. At One Ventures' investment portfolio includes companies across various sectors such as renewable energy, sustainable agriculture, and advanced materials. Notable investments include Noon Energy, which focuses on long-duration energy storage, and MightyFly, which is developing hybrid electric drone delivery systems. The firm's approach is hands-on, providing strategic guidance in talent acquisition, operations, marketing, IP strategy, and manufacturing. The team at At One Ventures consists of experienced professionals with backgrounds in physical sciences, engineering, manufacturing, and finance, ensuring a deep understanding of the technologies and markets they invest in. They operate globally, with a presence in San Francisco and London, and continue to seek partnerships with entrepreneurs, scientists, and investors who share their vision for a sustainable future.

Ataraxia VC is a global venture capital firm managing multiple funds, including the Social Starts and Joyance Partners funds, which focus on early-stage investments in health, happiness, and well-being. Ataraxia typically operates at the pre-seed and seed stages, with follow-on investments up to Series A. They target sectors like biotech, neuroscience, precision health, femtech, and next-gen food technologies. Their portfolio includes over 250 companies globally, with a strong focus on science-driven, transformative opportunities. The firm's strategy emphasizes investments in innovative companies that align with its vision of improving health and happiness through technology. With funds spread across the US and Europe, Ataraxia provides both capital and strategic guidance to help startups scale rapidly. They prioritize founders with groundbreaking solutions, especially in consumer tech, wellness, and sustainability-focused sectors. Key team members include Mike Edelhart, a seasoned investor with decades of experience, and Holly Jacobus, an investment partner with a focus on femtech, farmtech, and sustainable manufacturing. Ataraxia’s approach is hands-on, often providing mentorship and guidance through every stage of a startup’s journey​.

Atelier Ventures, founded by Li Jin, is an early-stage venture capital firm focused on the "Passion Economy," a concept that promotes enabling individuals to monetize their unique talents, creativity, and knowledge. This shift reflects the growing trend of people transitioning away from traditional employment toward independent work that aligns with their personal passions. Li Jin, who previously worked at Andreessen Horowitz, launched Atelier Ventures to fund companies that help democratize access to entrepreneurship. The firm’s investment thesis revolves around empowering creators by providing them with the tools, platforms, and resources to turn their individuality into income. Atelier Ventures supports startups building solutions that reduce the barriers to entry for entrepreneurship, including fintech platforms, SaaS tools, and educational services. These platforms facilitate the creation, distribution, and monetization of content, whether through podcasting, e-commerce, or other creative fields. Atelier Ventures focuses on businesses that promote independence while fostering community and collaboration among creators. Atelier’s portfolio includes companies that are reshaping the future of work by making it easier for creators to build and scale businesses. The firm envisions a future where creators, freelancers, and solopreneurs can collaborate in trusted networks and thrive in the digital age. This vision aligns with Li Jin's mission to support founders who challenge the status quo and create new, fulfilling work opportunities in the evolving digital landscape.

Atento Capital is a Tulsa-based venture capital firm founded with the mission of supporting early-stage tech startups, particularly those in underinvested communities. The firm was launched with backing from the George Kaiser Family Foundation, focusing on generating both market returns and social impact by funding innovative companies in the Heartland region of the U.S. Atento primarily invests in seed and early-stage companies, with check sizes ranging from $250,000 to $3 million. They are committed to fostering diversity in entrepreneurship, directing nearly half of their capital to underrepresented founders, including women and founders of color. Notable portfolio companies include RobbieAI, a platform using computer vision to prevent patient injuries, and PatchRx, a health tech solution aimed at improving medication adherence​. Beyond funding, Atento provides hands-on support to startups by offering mentorship, business development guidance, and access to local talent via partnerships with organizations like inTulsa. Their approach is deeply rooted in building long-term success for founders who have traditionally been overlooked by the broader venture capital ecosystem.

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Atlantic Bridge, founded in 2004, is a global growth equity technology firm that focuses on investing in deep technology companies across Europe, the UK, and the US. With over €1 billion in assets under management, the firm has a portfolio of 70 companies and has created over 5,000 jobs. Atlantic Bridge is known for its cross-border value-add strategy, helping portfolio companies expand internationally through its offices in Dublin, London, Munich, Paris, and Palo Alto. The firm's portfolio includes notable companies such as SOC Prime, which specializes in enterprise threat detection and response, and Elisity, which combines Zero Trust Network Access with an AI-enabled Software Defined Perimeter. Other significant investments include Siren, an investigative intelligence platform, and Aizon, which optimizes pharmaceutical manufacturing processes using real-time data and predictive models. Atlantic Bridge has achieved successful exits with companies like Navitas Semiconductor, which recently debuted its GaN Power ICs on Nasdaq, and Mitiga, a provider of hybrid managed services for incident response and readiness. The firm is led by experienced industry professionals, including Managing Partners Elaine Coughlan, Brian Long, and Kevin Dillon, who bring extensive expertise in scaling technology companies and executing successful IPOs and M&As.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlas Venture is a leading biotech venture capital firm focused on creating and building innovative life science companies. With over 30 years of experience, they have incubated over 70 startups and taken 40 companies public, including Intellia Therapeutics, Kymera Therapeutics, and Generation Bio. Atlas specializes in drug discovery and development, emphasizing areas like gene editing, oncology, and immunotherapy. Headquartered in Cambridge, Massachusetts, Atlas primarily targets U.S.-based startups but maintains a global vision, partnering with top scientific minds. They invest early, often leading seed and Series A rounds, with typical check sizes ranging from $5M to $20M. Atlas's approach is hands-on, actively incubating new ventures and co-founding companies with a strong operational focus. Key figures include Jean-François Formela, who has been instrumental in several high-profile exits and IPOs, and focuses on cutting-edge drug discovery technologies. Founders approaching Atlas should focus on breakthrough science with clear therapeutic applications, as the firm seeks to translate groundbreaking research into life-changing medicines.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

AtmosClear Investments is a Lausanne-based venture capital firm dedicated to accelerating the clean-tech revolution by investing in disruptive technologies that drive sustainability. Established in 2001, AtmosClear focuses on sectors like renewable energy, water purification, sustainable agriculture, and smart city infrastructure. Their diverse portfolio includes companies working on innovative solutions such as large-scale solar and wind energy projects, energy storage, recycling systems, and biofuels, with investments across Europe, particularly the UK and Switzerland. One of their notable ventures is Close the Loop, a recycling company specializing in repurposing ink cartridges, and they have also managed major solar installations in the UK, totaling over 30 MW. The firm’s mission is to generate both financial returns and positive environmental impact, emphasizing the reduction of harmful pollutants like microplastics and greenhouse gases. They support companies at various stages, from early startups to more mature businesses in need of growth capital​. AtmosClear’s team is led by experienced professionals with decades of expertise in finance and private markets. Founder Henry Sykes and his team leverage their deep knowledge to identify opportunities that align with their sustainability ethos. The firm’s global reach is underscored by investments in multiple continents, and they continue to seek out promising clean-tech entrepreneurs who share their vision of a more sustainable future. With a strong emphasis on long-term ecological benefits, AtmosClear is setting a new standard for responsible, impactful investing in the clean-tech space.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

ATP Fund, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm that focuses on deep tech investments aimed at advancing human conditions through scientific innovation. The firm specializes in sectors such as artificial intelligence (AI), biotechnology, cleantech, cybersecurity, enterprise software, healthcare, and robotics. ATP Fund is known for its strategic investments in startups that are tackling some of the most challenging and impactful problems of our time. ATP Fund adopts a contrarian and hands-on approach, often partnering with scientific entrepreneurs at the earliest stages of their ventures, sometimes even at the formation stage via their Proto.n initiative. This strategy reflects their commitment to long-term partnerships and their belief in the transformative potential of cutting-edge technologies. The fund's portfolio includes a variety of high-impact companies like Diligent Robotics, which focuses on healthcare robotics, and Infleqtion, a firm that specializes in quantum technology. These investments highlight ATP Fund's dedication to supporting ventures that have the potential to make significant advancements in their respective fields. ATP Fund collaborates with a wide network of co-investors, including notable names like Texas Venture Labs and Osage University Partners. The firm has also seen successful exits, further establishing its reputation as a key player in the deep tech investment landscape.

ATX Venture Partners, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm. The firm primarily invests in disruptive B2B software, APIs, marketplaces, frontier tech, and applications. Notable investments in their portfolio include companies like Aceable, AlertMedia, and Pensa Systems. Focusing on Seed and Series A stages, ATX Venture Partners operates with a strong preference for businesses that are already generating revenue. They actively invest across the United States, with a particular emphasis on the South-Central region. Their strategy involves partnering with entrepreneurs to create transformative technologies, aiming for category-defining outcomes in their respective industries. ATX Venture Partners is led by a team of experienced professionals including co-founders Chris Shonk, Brad Bentz, and Danielle Allen. Chris Shonk, known for his extensive background in both military operations and business, brings a wealth of experience in tech and consumer service investments. Brad Bentz combines expertise in finance, academia, and IT, while Danielle Allen leverages her extensive Wall Street background, focusing on finance and investments, particularly in space and women-led companies. Their investment approach is marked by a hands-on, collaborative ethos, aiming to propel portfolio companies towards larger growth. Entrepreneurs seeking investment are advised to approach ATX Venture Partners through detailed business plans, highlighting innovative solutions and market traction. Their recent investments, like the $1.7 million funding for Light Frame and the $1.9 million for LUXUS, underscore their commitment to fostering growth in cutting-edge sectors. For startups looking to partner with ATX Venture Partners, demonstrating product-market fit and a clear path to revenue generation is key.

Augment Ventures is a venture capital firm based in Ann Arbor, Michigan, specializing in early-stage investments across North America. The firm, founded in 2011 by Sonali Vijayavargiya, focuses on companies at the intersection of digital innovation and data utilization, particularly in sectors such as supply chain, fintech, industry 4.0, health tech, proptech, climate tech, B2B, and SaaS​. Notable investments by Augment Ventures include companies like LLamasoft, which was sold to Coupa Software for $1.5 billion, Optilogic, a cloud-native supply chain software solution, and Fluree, a platform recognized among the coolest data management companies​. Their portfolio also features innovative companies like Pair Team, Secro, Guardhat, and Crowdz, which span diverse industries from healthcare and fintech to supply chain and industrial safety. Augment Ventures emphasizes partnering with mission-oriented founders and diverse teams to address significant, real-world challenges. They provide not just capital but also strategic guidance and operational support to help startups scale and succeed in a constantly evolving global economy​.

August Capital is a venture capital firm founded in 1995, with a focus on backing innovative startups, primarily in the information technology sector. Based in Silicon Valley, August Capital has over $2 billion under management, making investments from early-stage startups to later-stage companies with high-growth potential. The firm has a strong track record of investing in transformative businesses like Splunk, Bill.com, and Atheros, helping entrepreneurs grow and scale their companies​. Unlike many venture capital firms, August Capital prides itself on taking a more personal approach to investing. They choose to work with fewer companies to provide more hands-on support. This includes helping founders with crucial aspects like talent recruitment, funding strategies, and customer acquisition. Their philosophy is that entrepreneurship is a team sport, and they aim to serve as a valuable resource for companies as they navigate the complexities of building successful ventures​. The team at August Capital includes highly experienced investors with deep networks and expertise across various tech sectors, making them well-positioned to support startups from inception through to potential exits. Their focus on early-stage investments allows them to nurture groundbreaking ideas and transform them into industry leaders.

Auriga Partners is a Paris-based venture capital firm established in 1998. The firm specializes in early-stage investments across various sectors, including information technology, life sciences, and cybersecurity. Auriga Partners has a strong focus on supporting high-potential ventures in Europe, North America, and Israel. Notable investments by Auriga Partners include Vade Secure, Nexthink, and Exeliom Biosciences. Vade Secure, a leader in predictive email defense, and Nexthink, a prominent analytics software provider, highlight Auriga’s commitment to backing innovative tech companies. Exeliom Biosciences, a biotech firm focused on the development of microbiome therapeutics, demonstrates their investment in life sciences. Auriga Partners has a robust portfolio with over 171 investments and 77 exits, reflecting their extensive experience and successful track record in venture capital. Their approach involves not only providing capital but also leveraging their expertise and network to support the growth and development of their portfolio companies. The team at Auriga Partners includes seasoned professionals like Philippe Granger, Mathieu Chatain, and Nabil Gharios, who bring significant industry knowledge and investment experience.

Authentic Ventures is a venture capital firm based in Oakland, California, focused on seed and early-stage investments. Founded in 2016 by Lindsay Lee JD, the firm targets a diverse range of industries, including enterprise software, consumer products, digital health, and deep tech sectors. Authentic Ventures emphasizes the importance of diversity and inclusivity, actively seeking to support women and minority founders who are tackling significant problems. The firm manages a concentrated portfolio, making 4-6 new investments annually, and works closely with its portfolio companies to ensure their success. Some notable investments include Verbal, Humans Anonymous, and Credit Mountain, highlighting their commitment to innovation and impactful solutions across various sectors. Authentic Ventures' team comprises experienced professionals, including Robin Bordoli, Amel Abdelwahid, and Michael Nichols JD, who collectively bring deep expertise in finance, compliance, and operations. The firm leverages a robust network to provide startups with the resources and connections needed to thrive.

Auxxo is a Berlin-based venture capital firm launched in 2019, specifically focused on driving diversity in venture capital by investing in female-founded startups. Its Female Catalyst Fund, led by Gesa Miczaika and Bettine Schmitz, aims to support pre-seed and seed-stage companies across Europe with at least one female co-founder. With a strong commitment to gender equity, Auxxo invests in a broad range of sectors including health care, fintech, biotech, and sustainability, often partnering with other VCs and family offices. Auxxo typically invests between €100k and €600k per round, positioning itself as a co-investor rather than a lead investor, and has built a portfolio of companies like Filu, Fermify, and Ubimaster. Auxxo has gained recognition for its mission to close the gender gap in VC, while empowering female entrepreneurs with strategic support and access to networks.

AV8 Ventures is a venture capital firm with a focus on early-stage investments in technology and healthcare sectors. Founded by George Ugras, who brings extensive experience from IBM Ventures and Apax Partners, AV8 Ventures operates primarily from Palo Alto and London. The firm leverages its deep expertise in applied AI, cloud computing, and big data to support transformative startups in these fields. The firm's investment strategy centers on identifying high-potential startups and providing them with not only capital but also strategic support and industry connections. AV8 Ventures emphasizes building long-term relationships with its portfolio companies, helping them scale and succeed in competitive markets. Notable investments by AV8 Ventures include companies like GrayMatter, which develops smart robotic solutions for manufacturing, and Precision Neuroscience, focusing on groundbreaking brain technology. These investments highlight AV8's commitment to supporting innovative technologies that address significant challenges in their respective industries. The team at AV8 Ventures, led by Ugras, comprises experienced professionals with backgrounds in venture capital, entrepreneurship, and technology development. This diverse expertise enables AV8 to provide comprehensive support to its portfolio companies, guiding them through various stages of growth and development. For startups looking to partner with AV8 Ventures, it’s essential to demonstrate strong technological foundations, clear market potential, and a vision for scalability and impact in the technology or healthcare sectors​.

Avalancha Ventures is a venture capital firm based in Mexico City, founded in 2015 by Lorenzo Garza and Rodrigo Ocejo. The firm focuses on early-stage investments, typically ranging from $50,000 to $300,000, with the potential for follow-on investments up to $2,000,000. Avalancha Ventures aims to support technology-driven companies that disrupt their target markets and show significant growth potential. Their portfolio includes notable investments such as Bind ERP, a cloud-based ERP platform for Mexican SMBs, and Syncfy, an open finance platform in Latin America. Other significant investments include Appaguitos.com, Bridgefy, WIHOM Software, and Carryt. These investments span across various industries including fintech, telecommunications, software, logistics, and e-commerce​. Avalancha Ventures is committed to helping its portfolio companies navigate their growth journeys, offering not just capital but also strategic support and expertise to help them scale and succeed in competitive markets.

Avalanche VC is a forward-thinking venture capital firm focused on transformative technologies at the intersection of how people learn, earn, and own. Founded by Katelyn Donnelly, Avalanche invests in early-stage startups that have the potential to ignite massive shifts in society—what they refer to as "avalanches." Their portfolio reflects this vision, featuring investments in groundbreaking companies like Agora, Humanly, and Bluesky. They are particularly drawn to sectors like EdTech, AI, and platforms that empower individuals to gain more autonomy in work and ownership. Geographically, Avalanche VC operates globally, with a strong emphasis on North America and Europe, always on the lookout for companies that can disrupt traditional systems on a massive scale. Their investment strategy is rooted in deep research and proprietary insights. They tend to invest early, typically with checks averaging around $1 million, and often prefer to follow rather than lead rounds. They are known for backing founders with a long-term vision—those who view their startups as their life’s work. Avalanche’s team brings a wealth of experience from tech, education, and government sectors, making them highly equipped to support portfolio companies beyond capital with strategic guidance and industry expertise. Startups looking to connect should emphasize their commitment to systemic change and demonstrate a clear understanding of the trends Avalanche is betting on for the future.

Avalon BioVentures, based in La Jolla, California, is a leading venture capital firm dedicated to early-stage biomedical innovation. With a $135 million fund, ABV1, Avalon BioVentures continues the legacy of Avalon Ventures by focusing exclusively on life sciences. Notable investments include Vertex Pharmaceuticals, Onyx Pharmaceuticals, Amira Pharmaceuticals, and Neurocrine Biosciences. More recent successes include Sitari Pharmaceuticals (acquired by GSK), Calporta (acquired by Merck), and Synthorx (acquired by Sanofi). Avalon BioVentures concentrates on biotechnology and life sciences, investing primarily in companies that are developing groundbreaking therapies for unmet clinical needs. Geographically, the firm focuses on the U.S., leveraging its strong presence in San Diego’s vibrant biotech hub. The firm’s strategy involves more than just capital; it includes active partnership through their integrated life science accelerator, providing essential resources, operational support, and strategic guidance from day one. Avalon BioVentures typically leads investment rounds, with average checks ranging from early seed funding to larger Series A investments. Key team members include Jay Lichter, Ph.D., an experienced biotech executive, Sanford J. Madigan, Ph.D., who has a rich background in corporate financing and business development, and Sergio G. Duron, Ph.D., known for his extensive experience in drug discovery and preclinical development. These leaders, among others, bring a combination of scientific expertise and entrepreneurial acumen, ensuring a hands-on approach to building successful biotech companies. Startups seeking investment should approach Avalon BioVentures with a clear vision for innovation in life sciences and a readiness to engage in a collaborative, entrepreneurial partnership.

Avalon Ventures is a San Diego-based venture capital firm with a focus on early-stage investments, particularly in life sciences and information technology. Founded in 1983, Avalon has a reputation for being one of the pioneering VCs in its field, actively seeking out companies with disruptive technologies and strong potential for market impact. Avalon tends to invest during the seed and Series A stages, with a preference for being the first institutional investor in many of its portfolio companies. The firm has made over 157 investments, with notable portfolio companies like Synthorx, Jnana Therapeutics, and Averon. Avalon is also known for its partnership with GlaxoSmithKline (GSK), which has helped launch several life science ventures through its joint funding efforts. Their long-term approach has led to several successful exits, including IPOs from companies like Kaltura and Janux Therapeutics. Avalon’s investment strategy revolves around identifying and nurturing innovative companies that align with their thesis-driven approach, focusing on emerging trends in both healthcare and tech sectors. The firm operates out of its offices in La Jolla, California, and Cambridge, Massachusetts, allowing it to maintain a strong presence on both coasts of the U.S. and globally.

Avant Global is a relationship-driven private investment firm founded in 1999, focused on leveraging high-level connections to foster innovative and high-growth companies. The firm has a global presence with offices in the USA, Greece, and the Philippines, and invests across various sectors including technology, healthcare, real estate, and consumer products​. Notable portfolio companies include The Healing Company, which focuses on healthcare and retail, Equiam, specializing in venture capital and asset management, and Jawbone Health, an information services and wellness company. Other significant investments are in innovative firms like Iron Ox, a leader in agricultural robotics, and BlueLayer, a software company based in Berlin​. The firm's founder and CEO, Demetri Argyropoulos, is known for his extensive network and strategic vision, having co-founded and invested in over 100 companies. He leads a seasoned team, including Executive Director George Vassilaras, who brings decades of experience in diverse industries and geographies​.